Skip to content
Insights
Distribution5 min read9 sections

Centralized vs. Decentralized vs. Hybrid Distribution

How harm reduction supplies reach the people who need them is not merely an operational question -- it is a matter of life and death. The difference between a naloxone kit arriving at a rural health department in 48 hours versus sitting in a state warehouse awaiting batch redistribution can determine whether a bystander has the tool to reverse an overdose. Across the United States, health departments, syringe services programs (SSPs), community-based organizations, and direct-ship distributors like Subcheck use three broad distribution architectures to move supplies from manufacturer to end user: centralized, decentralized, and hybrid models. Each carries distinct advantages in cost, speed, quality control, and geographic reach. This article examines all three in depth, drawing on published research, real-world program data, and lessons from adjacent fields including emergency management and pharmaceutical logistics, to help program administrators choose the right model -- or the right combination of models -- for their context.

01

What Is Hybrid Distribution?

A hybrid model blends centralized oversight with decentralized execution. Typically, a coordinating body handles bulk procurement, vendor management, and quality assurance centrally, while individual sites retain authority over ordering quantities, delivery timing, and last-mile distribution to clients. Subcheck operates on this principle: it ships direct-to-entity to more than 1,200 distribution points across nationwide, meaning that each site orders what it needs when it needs it, but the procurement, warehousing, and fulfillment infrastructure is centralized. The European Union\\

CentralizedDecentralizedHybrid
ControlHighLowMedium
Speed to end userSlow (2+ handoffs)Fast (direct)Fast (direct ship)
Inventory visibilitySingle warehousePer-site onlyReal-time, all sites
Expiration riskHigh (bulk aging)Low (small batches)Low (demand-based)
Staffing burdenCentral team onlyEvery siteShared
Best for<10 sitesIndependent orgs10+ sites, mixed geography
02

Last-Mile Delivery: The Hardest Problem in Public Health Logistics

Regardless of whether the upstream model is centralized, decentralized, or hybrid, the final leg of delivery -- getting supplies from a local warehouse, office, or vehicle into the hands of the person who needs them -- remains the most operationally complex and expensive segment. In healthcare logistics broadly, last-mile delivery accounts for a disproportionate share of total distribution cost. A DC Velocity analysis found that U.S. health systems cite high costs and delivery errors as persistent last-mile challenges, with problems including damaged packaging, delayed receipt, and incorrect labeling.

03

Direct-to-Entity Shipping vs. Warehouse-and-Redistribute

A fundamental architectural choice in public health distribution is whether to ship supplies directly from the fulfillment center to each endpoint (direct-to-entity) or to ship in bulk to an intermediary warehouse that then redistributes to local sites. Direct-to-entity shipping, sometimes called drop shipping in commercial logistics, eliminates the intermediate handling step. Each distribution point receives exactly what it ordered, when it ordered it, without waiting for a regional warehouse to break bulk and reship. This reduces transit time, minimizes handling damage, and allows sites to maintain leaner inventory since they can reorder on shorter cycles.

04

Vending Machines as Decentralized Distribution Nodes

Harm reduction vending machines have emerged as one of the most promising innovations in decentralized, low-barrier supply distribution. These machines, similar in form to conventional snack vending machines, are stocked with naloxone, sterile injection equipment, fentanyl test strips, condoms, sharps containers, first aid kits, and other supplies. They operate 24/7, require no staff interaction, and can be placed in high-traffic locations including emergency departments, jails, community treatment centers, probation offices, libraries, and transit hubs. The evidence base is growing rapidly.

Warehouse & redistribute
2415$/participant/yr
Direct-to-entity
730$/participant/yr
05

Mail-Based Distribution: Scaling Access Nationally

Mail-based distribution has emerged as a powerful tool for reaching individuals and small organizations that lack proximity to fixed distribution sites. NEXT Distro, the largest national mail-based harm reduction program, ships free naloxone and supplies directly to individuals\\

06

When to Switch Models: Decision Triggers and Transition Planning

No distribution model is permanent. Programs should evaluate their architecture when specific triggers arise. The most common triggers for moving from centralized to decentralized (or hybrid) distribution include: geographic expansion beyond a single region, where shipping times from a central warehouse begin to exceed acceptable delivery windows; volume growth that overwhelms central warehouse capacity or creates unacceptable order backlogs; client feedback indicating that supplies are not arriving quickly enough to meet acute need; and recurring disruptions at the central node, whether from weather, staffing, or vendor issues. Conversely, triggers for centralizing a fragmented decentralized system include: rising per-unit costs due to small-volume procurement across many sites; inconsistent product quality or expired inventory discovered at local sites; regulatory compliance failures stemming from lack of standardized processes; and difficulty aggregating data across sites for grant reporting or program evaluation.

07

Cost Comparison Across Distribution Models

Direct cost comparisons between distribution models depend heavily on program scale, geographic footprint, and product mix, but published data offers useful benchmarks. A study of SSP operating costs found that a fixed-site syringe services program spent $407,217 in its first year to serve 558 participants ($729.72 per participant), while a mobile unit serving the same population cost $311,626 but reached only 129 participants ($2,415.70 per participant). Intervention materials -- syringes, injection equipment, naloxone -- accounted for less than 15 percent of total program cost in both models; personnel and overhead dominated at over 85 percent. This finding has a critical implication for distribution model selection: the cost of the supplies themselves is a relatively small fraction of total program expense, which means that paying modestly more for shipping (as in a direct-to-entity model) can be more than offset by savings in warehousing labor, facility costs, and inventory management overhead. For centralized warehouse operations, the University of Pittsburgh Medical Center\\

When to Switch Models
If stock-outs exceed 5% of distribution days, if two or more sites report expired inventory, or if you expand beyond your original geography — it is time to reassess your distribution model.
08

Choosing the Right Model: A Decision Framework

Selecting a distribution model is not a one-size-fits-all exercise. The optimal choice depends on the intersection of several variables: program scale (number of distribution points and total supply volume), geographic spread (single metro area vs. multi-state), product complexity (room-temperature supplies vs. cold chain medications), organizational capacity (dedicated logistics staff vs.

Sources & References
  1. American Journal of Public Health. Funding and Delivery of Syringe Services Programs in the United States, 2022. Vol. 114, Issue 4, 2024. https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2024.307583 -- BMC Health Services Research. The hub-and-spoke organization design: an avenue for serving patients well. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5516840/ -- Boston Medical Center. Community Care in Reach: Mobilizing Harm Reduction and Addiction Treatment Services for Vulnerable Populations. PMC, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7545088/ -- California Department of Health Care Services. Naloxone Distribution Project. https://californiaopioidresponse.org/matproject/naloxone-distribution-project/ -- DC Velocity. Last-Mile Logistics Errors Impacting U.S. Health Systems. https://www.dcvelocity.com/transportation/trucking/last-mile/ -- FEMA. Distribution Management Plan Guide 2.0. January 2022. https://www.fema.gov/sites/default/files/documents/fema_distribution-management-plan-guide-2.0.pdf -- Frontiers in Public Health. Hybrid model: a promising type of public procurement in the healthcare sector of the European Union. 2024. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1359155/full -- Harm Reduction Journal. Expanding access to harm reduction in rural communities through community-informed public health vending machines. 2025. https://link.springer.com/article/10.1186/s12954-025-01395-6 -- Harm Reduction Journal. Implementation and first-year operating costs of an academic medical center-based syringe services program. 2021. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00563-8 -- Louisiana Department of Health. Harm Reduction Distribution Hub. https://www.louisianahealthhub.org/hrdhub/ -- MedCity News. Expanding Support for Mail-Based Naloxone Delivery. 2025. https://medcitynews.com/2025/05/expanding-support-for-mail-based-naloxone-delivery/ -- NASHP. Challenges and Opportunities for Strengthening Harm Reduction at the State Level. https://nashp.org/challenges-and-opportunities-for-strengthening-harm-reduction-at-the-state-level/ -- National Harm Reduction Coalition. Guide to Managing Programs: Module 2 Operational Issues. https://harmreduction.org/issues/syringe-access/guide-to-managing-programs/module-2-operational-issues/ -- NEXT Distro. FAQ. https://nextdistro.org/faq -- New Jersey Department of Health. Statewide Overdose Deaths Decline. March 2025. https://www.nj.gov/health/news/2025/approved/20250326a.shtml -- North Carolina DHHS. Syringe Service Program Models. https://www.ncdhhs.gov/divisions/public-health/north-carolina-safer-syringe-initiative/ssp-models -- PMC. Comparing Harm Reduction Vending Machines and In-Person Overdose Prevention Services in Practice: A Case Study From Rhode Island. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12097925/ -- PMC. Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8101586/ -- PMC. Harm reduction self-efficacy and motivations for contactless supply access. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12302801/ -- PMC. NEXT Harm Reduction: An Online Mail-Based Naloxone Distribution and Harm-Reduction Program. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC7958031/ -- PMC. Syringe services program operational changes during the COVID-19 global outbreak. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7290194/ -- PMC. Time- and Temperature-Controlled Transport: Supply Chain Challenges and Solutions. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC5821242/ -- PMC. Tribally-led mobile outreach: improving access to harm reduction services in one rural reservation community. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11137169/ -- Rural Health Information Hub. The Frontier of Harm Reduction: Expanding Services for Rural People Who Use Drugs. https://www.ruralhealthinfo.org/rural-monitor/harm-reduction -- Tennessee Harm Reduction. Supply-by-Mail Program. https://tennesseeharmreduction.com/ -- Wayne State University. Community-based naloxone distribution through the use of vending machines. https://behaviorhealthjustice.wayne.edu/vending-machines